Author

Y. Doyon

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Cancer Biology· 1 Cell Biology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Organism:human· 2 Assay:bulk RNA-seq· 1 Research Focus:cell type annotation· 1 Research Focus:drug response / drug discovery· 1 Approach:experimental assay· 1 Approach:genetic perturbation / CRISPR· 1

Frequent Co-Authors

J. Laganiere· 2 shared N. Dumont· 2 shared B. Boyle· 1 shared B. H. Nelson· 1 shared C. Goupil· 1 shared E. Normandeau· 1 shared G. Carleton· 1 shared G. Morin· 1 shared

Activity by Year

2022-2023 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 45 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

2 shared papersCancer Biology

J. Laganiere

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

Pharmacological control of CAR T cells through CRISPR-driven rapamycin resistance

S. Levesque, G. Carleton, V. Duque, C. Goupil, J.-P. Fiset, S. Villeneuve, E. Normandeau, G. Morin, N. Dumont, B. H. Nelson, J. Laganiere, B. Boyle, J. J. Lum, Y. Doyon

This study develops a CRISPR-based method to create rapamycin-resistant CAR-T cells, enabling pharmacological control of their activity in cancer therapy.

bioRxiv · Sep 14, 2023 · PreprintCancer Biology

Accessory-cell-free differentiation of hematopoietic stem and progenitor cells into mature red blood cells

Y. Boccacci, N. Dumont, Y. Doyon, J. Laganiere

This paper describes the differentiation of hematopoietic stem and progenitor cells into mature red blood cells without accessory cells or animal components, enabling storage for up to 42 days.

bioRxiv · Sep 14, 2022Cell Biology